Fidelity Advisor Financial Statements From 2010 to 2024
| FIJYX Fund | USD 30.70 0.48 1.59% |
Check Fidelity Advisor financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fidelity Advisor's main balance sheet or income statement drivers, such as , as well as many indicators such as . Fidelity financial statements analysis is a perfect complement when working with Fidelity Advisor Valuation or Volatility modules.
Fidelity |
Fidelity Advisor Biotechnology Mutual Fund One Year Return Analysis
Fidelity Advisor's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Fidelity Advisor One Year Return | 5.90 % |
Most of Fidelity Advisor's fundamental indicators, such as One Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fidelity Advisor Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Based on the recorded statements, Fidelity Advisor Biotechnology has an One Year Return of 5.9041%. This is 59.14% higher than that of the Fidelity Investments family and significantly higher than that of the Health category. The one year return for all United States funds is 42.27% lower than that of the firm.
Fidelity Advisor Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fidelity Advisor's current stock value. Our valuation model uses many indicators to compare Fidelity Advisor value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fidelity Advisor competition to find correlations between indicators driving Fidelity Advisor's intrinsic value. More Info.Fidelity Advisor Biotechnology is one of the top funds in annual yield among similar funds. It also is one of the top funds in year to date return among similar funds creating about 504.00 of Year To Date Return per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fidelity Advisor's earnings, one of the primary drivers of an investment's value.About Fidelity Advisor Financial Statements
Fidelity Advisor investors use historical fundamental indicators, such as Fidelity Advisor's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Fidelity Advisor. Please read more on our technical analysis and fundamental analysis pages.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuers financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Fidelity Mutual Fund
Fidelity Advisor financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Advisor security.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |